登录     注册     关注 (0)
0 项商品 ¥0
HER2c Her-2 IHC Bio-marker control TMA, with breast invasive ductal carcinoma, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/ 10 cores, replacing Her2b
Product Image
Cores 10 Cases 10
Row number 3 Column number 4
Core Diameter(mm) 1.5 Thickness(µm) 5.0
Tissue Array Type FFPE Species Human
QA/QC H&E, IHC Her-2/ER/PR/Ki67
Applications 常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH),可以在我们的技术支持页面找到操作流程。
Notes 1. 收到产品后请在4°保存,并在3个月内使用;
2. 请在实验前60°烤片30分钟;
3.请选择温和的修复方式,以免造成组织脱落。

HER2c

Her-2 IHC Biomarker control tissue microarray of breast invasive ductal carcinoma, containing 10 cases of invasive ductal carcinoma, single core per case

分类: Human Paraffin Embedded Tissue Array   Breast  

亚分类: Single core per case   Stage (TNM)  

  • ¥455
  • ¥455
  • 4 days left

请选择芯片类型

  • (280张)
  • (20张)

请添加确认数量

Alenabio
HER2c(serial)
1
2
3
4
A
Liv
-
Bre
Bre
B
Bre
Bre
Bre
Bre
C
Bre
Bre
Bre
Bre
HER2c  (-)
Age:-
Sex:
Organ(Anatomic Site):
Pathology diagnosis:
TNM:
Grade:
Stage:
Type:

Legend: --- Bre-Breast Liv-Liver

  • -
  • Malignant(IA)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(IIIA)
  • Malignant(IIIB)
Pos. No. Age Sex Organ Pathology diagnosis TNM Grade stage Type
A1 1 49 M Liver Hepatocellular carcinoma (tissue marker) T3N0M0 2 IIIA Malignant
A2 2 - - - Blank - - - -
A3 3 60 F Breast Invasive ductal carcinoma T2N0M0 2 IIA Malignant
A4 4 60 F Breast Invasive ductal carcinoma T3N0M0 2 IIB Malignant
B1 5 29 F Breast Invasive ductal carcinoma T2M0N0 2 IIA Malignant
B2 6 71 F Breast Invasive ductal carcinoma T1N0M0 2 IA Malignant
B3 7 75 F Breast Invasive ductal carcinoma T2N1M0 2 IIB Malignant
B4 8 49 F Breast Invasive ductal carcinoma T4N2M0 2 IIIB Malignant
C1 9 54 F Breast Invasive ductal carcinoma T3N0M0 2 IIB Malignant
C2 10 54 F Breast Invasive ductal carcinoma T3N1M0 3 IIIA Malignant
C3 11 36 F Breast Invasive ductal carcinoma T2N0M0 2 IIA Malignant
C4 12 38 F Breast Invasive ductal carcinoma T3N0M0 3 IIB Malignant
Notes:“*” means invalid core; “-” means no classification or negative in IHC markers.

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Pos. PR HER2 Ki67 ER
A1
A2
A3 - 3+ - -
A4 - 3+ +,5% -
B1 - 3+ +,10% +
B2 - 3+ +,2% -
B3 - 3+ +,5% +
B4 - 3+ +,20% -
C1 - 3+ +,5% -
C2 - 3+ +,5% -
C3 - 0 - -
C4 - 0 +,80% -